Needless to say, the past year, make that the past two years, has been rather hectic in the resveratrol world. Resveratrol went from the most obscure of health supplements to being the talk of all major news and media outlets. You couldn't turn your head without running into a resveratrol ad online, in food stores, or pharmacies. Simply put, Resveratrol was everywhere!
While resveratrol hasn't fallen off the radar of health enthusiasts, the "buzz" has certainly calmed down.
Is this a good thing and what does it mean for the future of resveratrol?
Those two questions are not easily answered, but here is my take on the subject...
First, the resveratrol phenomenon was both good and bad for the industry. It was bad in that numerous scams and deceptive companies sprung up like spring weeds. They claimed to solve every health problem under the sun and extend life indefinitely. Unfortunately, this caused a plethora of negative press and was not good for the industry.
The buzz was good in that it brought attention to a potentially very beneficial health supplement. Researchers, pharmaceutical companies, and health supplement suppliers began working in earnest to figure out if resveratrol could live up to its early claims. Research studies were started and completed (many still in progress) providing us with more information regarding the health benefits of resveratrol. While we still don't have many definitive answers I truly believe we have more than if the buzz never occurred.
Now on to the future of resveratrol! Resveratrol is by no means going away. Many health professionals and researchers still believe the benefits will eventually be proven and they continue to study them feverishly. You can be sure that there WILL be answers provided in the coming years. Will they be good or bad? Good question!
What do you think... has the buzz been good, bad, or indifferent? Where will resveratrol be in the next 5-10 years?






I assume bad news doesn't belong to the experience?
Glaxo's 'Red Wine' Drug Trial Halted Over Safety Concerns
In a possible setback for scientists attempting to make drugs out of a substance found in red wine, GlaxoSmithKline PLC said a clinical trial of one drug in cancer patients has been halted due to safety concerns.
Glaxo acquired the drug in 2008 when it paid $720 million for Sirtris Pharmaceuticals, a biotech company in Cambridge, Mass. The drug, known as SRT501, contains a reformulated version of resveratrol, a substance found in low quantities in red wine.
http://online.wsj.com/article/SB10001424052748703866704575224110336797160.html?mod=WSJ_hps_LEFTWhatsNews
Posted by: Posta | May 05, 2010 at 11:41 AM
All news is welcome, including bad news. You will find plenty of it on this site, especially if you read the "side effects" sections.
Thank you for finding this information and posting it.
Posted by: Admin | May 05, 2010 at 12:04 PM
I believe that resveratrol was and still will be popular.
Posted by: Resveratrol | June 16, 2010 at 09:25 AM